BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martín-Montañez E, Valverde N, Ladrón de Guevara-Miranda D, Lara E, Romero-Zerbo YS, Millon C, Boraldi F, Ávila-Gámiz F, Pérez-Cano AM, Garrido-Gil P, Labandeira-Garcia JL, Santin LJ, Pavia J, Garcia-Fernandez M. Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease. Redox Biol 2021;46:102095. [PMID: 34418603 DOI: 10.1016/j.redox.2021.102095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Xu N, Yu K, Wang X, Gu J, Yu L, An J, Wang Y, Dong M, Sun C, Zhang J, Zhao N, Liu W, Han X. The Neuroprotective Mechanism of IGF-2 in Neuromyelitis optica spectrum disorder.. [DOI: 10.21203/rs.3.rs-2542972/v1] [Reference Citation Analysis]
2 Zhang HY, Jiang YC, Li JR, Yan JN, Wang XJ, Shen JB, Ke KF, Gu XS. Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson's disease. Neural Regen Res 2023;18:1099-106. [PMID: 36254999 DOI: 10.4103/1673-5374.355815] [Reference Citation Analysis]
3 Luo W, Pryzbyl KJ, Bigio EH, Weintraub S, Mesulam M, Redei EE. Reduced Hippocampal and Anterior Cingulate Expression of Antioxidant Enzymes and Membrane Progesterone Receptors in Alzheimer’s Disease with Depression. JAD 2022. [DOI: 10.3233/jad-220574] [Reference Citation Analysis]
4 Ma Y, Rong Q. Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson's Disease. Contrast Media Mol Imaging 2022;2022:2112146. [PMID: 35299590 DOI: 10.1155/2022/2112146] [Reference Citation Analysis]
5 Sepúlveda D, Grunenwald F, Vidal A, Troncoso-Escudero P, Cisternas-Olmedo M, Villagra R, Vergara P, Aguilera C, Nassif M, Vidal RL. Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson's disease. Sci Rep 2022;12:2038. [PMID: 35132125 DOI: 10.1038/s41598-022-05941-1] [Reference Citation Analysis]
6 Claros S, Cabrera P, Valverde N, Romero-zerbo SY, López-gonzález MV, Shumilov K, Rivera A, Pavia J, Martín-montañez E, Garcia-fernandez M. Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons. Antioxidants 2021;11:41. [DOI: 10.3390/antiox11010041] [Reference Citation Analysis]